Novartis CEO on pharma tariffs, raised outlook, competition
00:00 Speaker A Swiss drug maker Novartis boosting its full year profit outlook after strong second-quarter revenue growth driven by continued demand for key drugs. Now, despite the forecast boost, those shares are trading slightly lower. Let's talk …